Veterans Aging Cohort Study (VACS) 1.0 Index
Why Use
Traditional mortality estimates using only viral load or CD4 count in HIV or FIB-4 in Hepatitis C are inaccurate; the VACS Index looks adds additional markers to estimate multi-organ system involvement and more-accurately predict mortality.
When to Use
Aids in prognostication in patients with HIV or Hepatitis C. Potentially useful with goals of care planning or aggressiveness of therapy.
Formula
Pearls / Pitfalls
The VACS Index comes from a US VA population, so most patients in both the derivation and validation cohorts were men. Half of patients had started anti-retrovirals prior to 2004, so it is unknown how the newer anti-retrovirals may affect these estimates. <5% of patients in this study were ≥65 years old so this is likely less accurate in older populations. Few patients in the study had significant renal disease: >90% had an eGFR ≥60.
Critical Actions
Because half of the patients in the study had started anti-retrovirals prior to 2004, it is unknown how newer anti-retrovirals may affect the score's estimates. Use clinical judgement when planning care or aggressiveness of therapy.
More Information
Criteria Value Points Age <50 years 0 50-64 years +12 ≥60 years +27 CD4 ≥500 cells/mm 3 0 350-499 cells/mm 3 +6 200-349 cells/mm 3 +6 100-199 cells/mm 3 +10 50-100 cells/mm 3 +28 <50 cells/mm 3 +29 HIV-1 RNA <500 copies/mL 0 500-99,999 copies/mL +7 ≥1x10& 5 copies/mL +14 Hemoglobin ≥14 g/dL 0 12-13.9 g/dL +10 10-11.9 g/dL +22 <10 g/dL +38 FIB-4 <1.45 0 1.45-3.25 +6 >3.25 +25 eGFR ≥60 mL/min 0 45-59.9 mL/min +6 30-44.9 mL/min +8 <30 mL/min +26 Hepatitis C Co-Infection No 0 Yes +5